Mealey's (February 26, 2020, 9:50 AM EST) -- WASHINGTON, D.C. — In a Feb. 25 order, the Federal Circuit U.S. Court of Appeals rejected efforts by patent owners to revisit its October ruling that affirmed a judgment of invalidity and noninfringement with regard to various patents covering methods of treating osteoarthritis (HZNP Medicines LLC, et al. v. Actavis Laboratories UT Inc., Nos. 2017-2149, -2152, -2153, -2202, -2203, -2206, Fed. Cir., 2020 U.S. App. LEXIS 5693)....